The growth of the overall Organ Preservation Solution Market can be contributed to rising multi-organ failure cases in aging population, technological advancements, increasing government initiatives to promote organ donation and rising number of solid-organ transplant procedures. In the coming years, the market is expected to witness the highest growth rate in the Asia-Pacific region. North America is expected to account for the largest share of the global market. However, high cost of transplantation is likely to restrain the growth of the market during the forecast period.
–>Global Industry Segmentation<–
Based on organ type, the market is segmented into kidneys, liver, lung, heart and others (pancreas & intestine). In 2016, the kidneys segment is estimated to account for the major share of the Organ Preservation Solution Market. The growth of this segment can be attributed to factors such as rising cases of kidney failure, improvements in graft survival, and long-term graft function.
Based on preservation solutions, the market is segmented into university of wisconsin solution, custodiol HTK, perfadex and others (celsior & euro-collins). In 2016, the university of wisconsin solution segment is estimated to account for the major share of the Organ Preservation Solution Market. This large share can be attributed to its prolific usage in the storage of kidney, liver, and pancreas, better transplantation outcomes, less histological damage, and improved physiological function of organs.
Feel Free to Talk to Our Research Experts for More Detailed Information
Based on transportation technique, the market is segmented into static cold storage, hypothermic machine perfusion and normothermic machine perfusion. In 2016, the static cold storage segment is estimated to account for the major share of the Organ Preservation Solution Market. The largest share of static cold storage can be attributed to the simplicity, low cost, and less requirement of equipment and trained personnel.
On the basis of region, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2016, North America is expected to account for the largest share of the Organ Preservation Solution Market. Its large share can be attributed to growing cases of kidney failure, rising organ transplants, favorable reimbursements scenario within some provinces in Canada, and novel technological advancements by U.S. players. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period due to the new regulatory framework in China, and increasing organ donations in Asia-Pacific and serve as a revenue pocket for companies offering organ preservation solutions and transport systems.
Major Industry Leaders:
The major players in the Organ Preservation Solution Market include Organ Recovery Systems (U.S.), Xvivo Perfusion AB (Sweden), Essential Pharmaceuticals (U.S.), Dr. Franz Kohler Chemie GmbH (Germany), and Waters Medical Systems LLC (U.S.), among others.
Target Audience:
Preservation Solutions and Devices Providers
Life Sciences Companies
Medical Device Manufacturers
Market Research and Consulting Firms
Healthcare Service Providers
Medical Research Institutes
Regulatory Bodies
Venture Capitalists
Read More@
https://www.marketsandmarkets.com/Market-Reports/organ-preservation-market-261269915.html
